RT Journal Article
SR Electronic
T1 Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.26.20248878
DO 10.1101/2020.12.26.20248878
A1 Brown, Timothy A.
A1 Schaefer, Katherine S.
A1 Tsang, Arthur
A1 Yi, Hyun Ah
A1 Grimm, Jonathan B.
A1 Lemire, Andrew L.
A1 Jradi, Fadi M.
A1 Kim, Charles
A1 McGowan, Kevin
A1 Ritola, Kimberly
A1 Armstrong, Derek T.
A1 Mostafa, Heba H.
A1 Korff, Wyatt
A1 Vale, Ronald D.
A1 Lavis, Luke D.
YR 2021
UL http://medrxiv.org/content/early/2021/01/11/2020.12.26.20248878.abstract
AB The worldwide COVID-19 pandemic has had devastating effects on health, healthcare infrastructure, social structure, and economics. One of the limiting factors in containing the spread of this virus has been the lack of widespread availability of fast, inexpensive, and reliable methods for testing of individuals. Frequent screening for infected and often asymptomatic people is a cornerstone of pandemic management plans. Here, we introduce two pH sensitive ‘LAMPshade’ dyes as novel readouts in an isothermal RT-LAMP amplification assay for SARS-CoV-2 RNA. The resulting JaneliaLAMP (jLAMP) assay is robust, simple, inexpensive, has low technical requirements and we describe its use and performance in direct testing of contrived and clinical samples without RNA extraction.Competing Interest StatementH.M acknowledges research collaboration and contribution with equipment and reagents from Bio-Rad Laboratories and DiaSorin Molecular. Research collaborations with BD diagnostics and honoraria from GenMark.Funding StatementThis work was supported by the Howard Hughes Medical Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB for research on patient samples approved via Johns Hopkins University Medical School.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no external links to remote data. All data are included in the manuscript.